Abstract
We report a click-chemistry based modular strategy for antibody labeling with 64Cu (t1/2 = 12.7 h; β+ 0.656 MeV, 17.4%; β- 0.573 MeV, 39%; EC 43%) under ambient condition utilizing a cross-bridged tetraazamacrocyclic (CB-TE2A) analogue, which otherwise requires harsh conditions that make the CB-TE2A analogues under-utilized for protein labeling despite the fact that they form kinetically inert copper complexes with high in vivo stability. Our strategy involves prelabeling a CB-TE2A based scaffold (CB-TE2A-1C) with 64Cu and its subsequent reaction with an antibody via the tetrazine-norbornene mediated click chemistry. The effectiveness of this strategy was demonstrated by labeling two monoclonal antibodies, an anti-PSMA antibody (YPSMA-1) and a chimeric anti-phosphatidylserine antibody (Bavituximab). The immunoreactivity of the antibodies remained unchanged after the tetrazine modification and click-chemistry 64Cu labeling. To further demonstrate the practicality of the modular 64Cu labeling strategy, we tested positron emission tomography (PET) imaging of tumor with the 64Cu-labeled bavituximab in a mouse xenograft model. The tumor visualization and uptake of the labeled antibody exhibited the versatility of the click-chemistry strategy.
Original language | English (US) |
---|---|
Pages (from-to) | 782-789 |
Number of pages | 8 |
Journal | Bioconjugate Chemistry |
Volume | 26 |
Issue number | 4 |
DOIs | |
State | Published - Apr 15 2015 |
ASJC Scopus subject areas
- Biotechnology
- Bioengineering
- Biomedical Engineering
- Pharmacology
- Pharmaceutical Science
- Organic Chemistry